Mr. Bar Shalev joined our Board of Directors in July 2008. Previously, Mr. Bar Shalev served as a director of Protalix Ltd. from 2005 through January 2008, and as our director from 2006 through January 2008. Mr. Bar Shalev brings to us extensive experience in managing technology companies. Since 2011, Mr. Bar Shalev has served on the Board of Directors of Interna Therapeutics Ltd. (formerly, Aposense Ltd.), a privately-held pharmaceutical company. He served on the Board of Directors of Sirvir Ltd., a privately held pharmaceutical company and subsidiary of Interna Therapeutics, from 2014 through its merger into Interna Therapeutics in November 2024. From 2004 through 2012, Mr. Bar Shalev served as a director of Technorov Holdings (1993) Ltd. and managed its portfolio. From 1997 through 2004, he was a Managing Director of TDA Capital Partners, a management company of the TGF (Templeton Tadiran) Fund. From 2004 through 2007, he was the President of Win Buyer Ltd. He has served on the Board of Directors of a number of Israeli publicly traded and privately-held Israeli companies including, among others, Ripple Ltd. (formerly, Steam CC Ltd.), Velox Ltd., NESS Ltd. (acquired by BioNess Inc.), Idanit (acquired by Scitex Corporation Ltd.), Objet Geometrix (merged with Stratasys, Inc. (NASDAQ:SSYS)), Verisity, Scitex Vision (acquired by Hewlett Packard (NYSE:HPE)), Golden Wings Investment Company Ltd., the venture capital fund of the Israeli Air Force Veterans Business Club, Win Buyer Ltd. and Sun Light Ltd. Mr. Bar Shalev holds a B.Sc. in Electrical Engineering from the Technion, Israel Institute of Technology and an MBA from the Tel Aviv University in 1981. He holds the highest award from the Israeli Air Force for technological achievements.
How do I contact Amos Bar-Shalev?
Has Amos Bar-Shalev been buying or selling shares of Protalix BioTherapeutics?
Amos Bar-Shalev has not been actively trading shares of Protalix BioTherapeutics during the last ninety days. Most recently, Amos Bar-Shalev sold 168 shares of the business's stock in a transaction on Tuesday, November 18th. The shares were sold at an average price of $1.87, for a transaction totalling $314.16. Learn More on Amos Bar-Shalev's trading history.
Who are Protalix BioTherapeutics' active insiders?
Are insiders buying or selling shares of Protalix BioTherapeutics?
In the last year, Protalix BioTherapeutics insiders bought shares 1 times. They purchased a total of 56,000 shares worth more than $101,360.00. In the last year, insiders at the sold shares 2 times. They sold a total of 336 shares worth more than $628.32. The most recent insider tranaction occured on December, 19th when CEO Dror Bashan bought 56,000 shares worth more than $101,360.00. Insiders at Protalix BioTherapeutics own 6.7% of the company.
Learn More about insider trades at Protalix BioTherapeutics. Information on this page was last updated on 12/19/2025.
